ALKERMES | Credores Comerciais



Trade Creditors Alterar Data
AbbVie 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
ALKERMES USD 45.63M 8.59M 2024-12
Amgen USD 1.91B 239M 2024-12
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Gilead Sciences USD 833M 70M 2024-12
Intra Cellular Therapies USD 26.07M 15.74M 2024-12
Ionis Pharmaceuticals USD 42.96M 33.91M 2024-12
J&J USD 10.31B 1.36B 2024-12
Malin Corporation EUR 500K 500K 2024-06
Merck USD 4.08B 493M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Otsuka Holdings JPY 220B 37.22B 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



ALKERMES Credores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.